Status: current, Defined. Date: 28-Feb 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3214231000168119 | Hizentra (normal immunoglobulin human 2 g / 10 mL) injection, 10 mL syringe (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3214241000168111 | Hizentra 2 g/10 mL injection, 10 mL syringe | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Hizentra 2 g/10 mL injection, 10 mL syringe | Is a | normal immunoglobulin 2 g/10 mL injection, syringe | true | Inferred relationship | Some | ||
| Hizentra 2 g/10 mL injection, 10 mL syringe | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Hizentra 2 g/10 mL injection, 10 mL syringe | Is a | Hizentra | true | Inferred relationship | Some | ||
| Hizentra 2 g/10 mL injection, 10 mL syringe | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Hizentra 2 g/10 mL injection, 10 mL syringe | has unit of use | syringe | true | Inferred relationship | Some | 1349601959 | |
| Hizentra 2 g/10 mL injection, 10 mL syringe | has intended active ingredient | normal immunoglobulin | true | Inferred relationship | Some | 1349601958 | |
| Hizentra 2 g/10 mL injection, 10 mL syringe | has Australian BoSS | normal immunoglobulin | true | Inferred relationship | Some | 1349601958 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hizentra 2 g/10 mL injection, 10 mL syringe | has TPUU | True | Hizentra 2 g/10 mL injection, 10 mL syringe | Inferred relationship | Some | 1 |
| Hizentra 2 g/10 mL injection, 10 mL syringe | has TPUU | True | Hizentra 2 g/10 mL injection, 10 mL syringe | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR